الفهرس 
-Chapter (I) Third stage of labourOnly 14 pages are availabe for public view
 |  | from | 99 |  |  |
| | | from | 99 | | |
Abstract
This study was a randomized trial which was conducted at the department of Obstetrics and Gynecology of Qwesna central hospital after obtaining their approval. The study participants were 150 women in their third stage of labor divided into 3 groups with a ratio 1:1:1. This trial was for studying the role of the effect of sublingual misoprostol and intraumbilical oxytocin injection at the third stage of labour and whether they had additional benefit to the control group or not. The primary outcome measures focused on calculation the duration of third stage of labour and the amount of blood loss in third stage up to 1 hour after delivery. The secondary outcome measures included DROP in hemoglobin level, requirements of additional oxytocic agents, need for manual removal of placenta, need for blood transfusion, additional surgical interventions, and maternal complications as shock, renal failure or maternal mortality and adverse effects related to agents used in the study. Results showed no significant group differences in maternal age, parity, birth weight and placental weight. Also, it showed no significant differences in the duration of third stage between 3 groups as it was (6.231±1.91) in the control group, (5.58±2.29) in intraumbilical group and (6.244±2.35) in misoprostol group and as regard mean amount of blood loss, it was found that there was no significant difference between the 3 groups as it was (180.94±45.914) in control group, (168.88±40.99) in intraumbilical group and (144.1±28.24) in misoprostol group. It was found that there was no significant change in pre_delivery and post-delivery hemoglobin and hematocrit at intraumbilical oxytocin and sublingual misoprostol groups in versus to the control group.